Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Condie, US

Brent Condie, Worley, ID US

Patent application numberDescriptionPublished
20090108490Material curing constructions and methods for curing material - Form inserts are provided that can include a flexible sheet having multiple ribs extending from at least one surface of the sheet. Methods for curing material are provided that can include expanding a sheet over an interior portion of one form defining a perimeter of material to be cured. The sheet can include ribs extending from a surface of the sheet to within the perimeter. Column form inserts are also provided that can include a plurality of circular ribs defining a perimeter of a column form. Methods of producing a form insert comprising providing a sheet of flexible material and adhering a flexible mesh to the sheet, the flexible mesh forming ribs extending from at least one surface of the sheet, are also provided.04-30-2009
20090233054Material Curing Constructions and Methods for Curing Material - Multi-layer concrete forms are provided that can include outer layers having a scrim layer there between. The forms may include a form section having four edges, wherein at least two of the edges are configured to abut one another; and a flange section extending from at least one of the other four edges. Processes for constructing a concrete form are provided with the process including providing a substantially flat section of form to a construction site, with the section having four edges; substantially abutting at least two of the edges to create a tubular form; and heat sealing the edges.09-17-2009

Brian G. Condie, Athens, GA US

Patent application numberDescriptionPublished
20090035285Compositions and Methods for Enrichment of Neural Stem Cells Using Ceramide Analogs - The present invention provides compositions and methods for human neural cell production. More particularly, the present invention provides cellular differentiation methods employing amphiphilic lipid compounds, preferably ceramide analogs of the β-hydroxyalkylamine type and optionally employing an essentially serum free MEDII conditioned medium for the generation of human neural cells from pluripotent human cells. The methods alternatively comprise modulating apoptosis by modifying the levels of PAR-4, with or without the presence of amphiphilic lipid compounds and optionally employing MEDII conditioned medium. The methods alternatively encompass modulating apoptosis by modulating the intracellular concentration of endogenous lipid second messengers, such as ceramide.02-05-2009

Brian W. Condie, Mesa, AZ US

Patent application numberDescriptionPublished
20090001614SEMICONDUCTOR DEVICE WITH A BUFFER REGION WITH TIGHTLY-PACKED FILLER PARTICLES - An embodiment of a semiconductor device includes a supporting member, a semiconductor die mounted on a portion of the supporting member, a buffer region, and a plastic encapsulation. The buffer region covers a portion of the die, and includes a resin and filler particles packed within the resin. The filler particles have a mix of filler sizes and are tightly packed within the resin. The buffer region has a first dielectric constant and a first loss tangent. The plastic encapsulation encloses at least part of the supporting member and the die. The plastic encapsulation includes a plastic material of a second dielectric constant and a second loss tangent, where the second dielectric constant is larger than the first dielectric constant and the second loss tangent is larger than the first loss tangent.01-01-2009

Patent applications by Brian W. Condie, Mesa, AZ US

Catherine R. Condie, Shoreview, MN US

Patent application numberDescriptionPublished
20090209880METHOD AND APPARATUS TO DETECT AND MONITOR THE FREQUENCY OF OBSTRUCTIVE SLEEP APNEA - The present invention provides a method and apparatus for detecting and monitoring obstructive sleep apnea. The apparatus includes an intracardiac impedance sensor to measure intracardiac impedance, a movement sensor to measure an amount of movement of a patient, and a controller operatively coupled to said intracardiac impedance sensor and said movement sensor, said controller adapted to receive at least one of an intracardiac impedance and the amount of movement of the patient and detect obstructive sleep apnea based upon said intracardiac impedance and said movement.08-20-2009
20090299422ELECTROGRAM STORAGE FOR SUSPECTED NON-PHYSIOLOGICAL EPISODES - Techniques for storing electrograms (EGMS) that are associated with sensed episodes or events that may be non-physiological and, instead, associated with a sensing integrity condition are described. In some examples, a device or system identifies suspected non-physiological NSTs, and stores an EGM for the suspected non-physiological NSTs within an episode log. In some examples, a device or system determines whether to store an EGM for a suspected non-physiological episode or event based on whether an impedance integrity criterion has been satisfied. For example, a device or system may store an EGM for a detected short interval if the impedance integrity criterion has been met. In some examples, a device or system determines whether to buffer EGM data based on whether an impedance integrity criterion or other sensing integrity criterion has been met.12-03-2009
20100030289PRE-QUALIFICATION OF AN ALTERNATE SENSING CONFIGURATION - Multiple sensing configurations may be qualified based on one induced tachyarrhythmia, e.g., ventricular fibrillation, or other qualification event during an implantation procedure. Each sensing configuration comprises a different combination of two or more electrodes used for sensing electrical signals of the heart of the patient. In some examples, an implantable medical device or other device generates qualification information for each sensing configuration, which may indicate whether the sensing configuration is qualified for subsequent cardiac event detection based on an accuracy of the cardiac event detection for the sensing configuration during the qualification event. One of the qualified configurations may initially be selected as a primary sensing configuration for subsequent cardiac event detection. Switching to an alternate sensing configuration, e.g., upon identification of any sensing integrity condition of the primary sensing configuration, may be expedited by the previous collection of qualification data for at least one other sensing configuration.02-04-2010
20110184299SYSTEM AND METHOD OF USING AV CONDUCTION TIMING - In an implantable medical device that provides atrial and ventricular pacing in an atrial-based pacing mode, longer periods of time are permitted for intrinsic AV conduction to occur. By monitoring the patient's AV delay under these circumstances, useful information is obtained that can be correlated to other patient conditions or symptoms.07-28-2011

Patent applications by Catherine R. Condie, Shoreview, MN US

Keith G. Condie, Idaho Falls, ID US

Patent application numberDescriptionPublished
20080205483HIGH TEMPERATURE THERMOCOUPLE DESIGN AND FABRICATION - A method for fabricating a thermocouple capable of long-term operation in high temperature, hostile environments without significant signal degradation or shortened thermocouple lifetime due to heat induced brittleness.08-28-2008
20100254503APPARATUS AND SYSTEMS FOR MEASURING ELONGATION OF OBJECTS, METHODS OF MEASURING, AND REACTOR - Elongation measurement apparatuses and systems comprise at least two Linear Variable Differential Transformers (LVDTs) with a push rod coupled to each of the at least two LVDTs at one longitudinal end thereof. At least one push rod extends to a base and is coupled thereto at an opposing longitudinal end, and at least one other push rod extends to a location spaced apart from the base and is configured to receive a sample between an opposing longitudinal end of the at least one other push rod and the base. Nuclear reactors comprising such apparatuses and systems and methods of measuring elongation of a material are also disclosed.10-07-2010

Russell Morris Condie, Salt Lake City, UT US

Patent application numberDescriptionPublished
20110306581STABLE PERFLUOROCARBON EMULSION FOR USE AS AN ARTIFICIAL OXYGEN CARRIER - Perfluorocarbon emulsions having a high stability and good oxygen release are disclosed and described. These perfluorocarbon emulsions are typically for use as artificial oxygen carriers. The perfluorocarbon emulsions include a disperse phase of a perfluorocarbon and an emulsion stabilizer, and continuous phase. The emulsion stabilizer can primarily include a poly(ethylene oxide) block copolymer. These stabilized perfluorocarbon emulsions can be used in liquid and/or hydrogel phases of perfusion bioreactors or various other culture systems to enhance cell viability in thick tissue constructs, or as blood substitutes, although other applications may also be considered.12-15-2011

Shaun Condie, Provo, UT US

Patent application numberDescriptionPublished
20100057004Extravascular System In-Line Venting - An extravascular system may include a fluid path and a gas vent in communication with the fluid path. A method of venting a medical device may include providing a closed extravascular system having a fluid path, providing a gas vent in communication with the fluid path, venting gas from the extravascular system through the gas vent, and maintaining closure of the extravascular system during and after venting.03-04-2010